Not Found
On Demand

Update on Anti-Obesity Medications – Nicholas Pennings, DO

Total Credits: .75 including .75 AOA Category 1-A Credit(s)

Average Rating:
State Associations:
NCOMA - North Carolina
Nicholas Pennings
50 Minutes
Never expires.


Update on Anti-Obesity Medications
Session Objectives

  1.  Recognize the rationale for using anti-obesity medications.
  2.  Utilize FDA approved medications for obesity treatment.
  3.  Identify the role of medications not approved by the FDA in weight management.
  4.  Identify medications under investigation for obesity treatment.

    The North Carolina Osteopathic Medical Association is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians and designates this program for a maximum of .75 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.

The speaker for this session did not have disclosures that presented a conflict of interest.



Nicholas Pennings's Profile

Nicholas Pennings Related seminars and products

Dr. Pennings is Chair of the Family Medicine Department, Associate Professor at the Campbell University School of Osteopathic Medicine and Director of the Campbell University Health Center.  He is a graduate of the Philadelphia College of Osteopathic Medicine and is Board Certified in Family Medicine & Obesity Medicine.  Dr. Pennings is a fellow of the Obesity Medicine Association and an Executive Director of Clinical Education for the OMA.  

Alternate Options

Common Pain Procedures – Quan Luong, DO
Original Program Date: 08/21/2020
Concussion Update – Andrew Martin, DO
Original Program Date: 08/26/2020
The Victim as Your Patient Marta Bringhurst, DO
Original Program Date: 08/26/2020
ECG and the Athletic Heart – Flint Ray, DO
Original Program Date: 08/26/2020
OMT for Headaches – Eric Gish, DO
Original Program Date: 08/26/2020
OMT for the Lower Extremity – Gregory Hon, DO
Original Program Date: 08/27/2020

Please wait ...

Back to Top